Search

everythinglearnresearchcommunity

for

Search:↓

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Baricitinib was effective in treating alopecia areata in two major trials.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

The right dosage of CPA and TB can work as a safe and reversible male contraceptive in monkeys.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Topical cetirizine 1% increases hair density and may be a promising treatment for hair loss.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

A man's hair loss was linked to his HIV medication, which improved after changing drugs.

The combination of encorafenib and binimetinib caused few skin issues.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Tretinoin lotion can remove hair casts, which come from a specific part of the hair follicle and can be classified into two types.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Baricitinib helps regrow hair in teens with severe alopecia areata.

PRP and IT are equally effective for treating localized alopecia areata, but PRP causes more pain and bleeding.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Lower doses of topotecan are safe for eyes, but higher doses may harm the retina.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Oral retinoids like isotretinoin and acitretin can cause significant hair loss.